CHEMOTHERAPY & TARGETED THERAPIES

Index of Recent Stories

Advanced Prostate Cancer Treatable After Chemo Holidays Treatment holidays improve quality of life. June 5, 2006.

Cancer therapy based on anatomical location may soon be obsolete April 19 2006

Vitamin D, Taxotere Combination Promising For Advanced Prostate Cancer Aug 8, 2005

Novacea Initiates Pivotal Phase 3 Clinical Study of DN-101 in Men With Advanced Prostate Cancer April 12, 2006

Treatment Related Side Effects of Chemotherapy with TAXOTERE (Docetaxel) in Men with Prostate Cancer December 2005

Phenoxodiol Delays Progression in Hormone Refractory Prostate Cancer,
No side-effects, study says Nov 17, 2005

Intermittent Taxotere/Calcitriol chemotherapy feasible in treatment of advanced prostate cancer. Treatment "holidays" may allow disease to be managed as chronic, rather then acute, condition. Oregon Health & Science University (OHSU), June 2003

Results for OncoGenex drug in early prostate cancer trial, Phase II trial enrolling Positive data from a phase I study of OncoGenex Technologies' OGX-011, a cancer drug found to sensitize tumors to standard therapy by targeting clusterin, leads to Phase II trials for prostate and lung cancers. September 11, 2005

Cancer and Chemotherapy Fatigue July 2005

Men with advanced, hormone refractory prostate cancer can benefit from docetaxel (Taxotere) Compared to mitoxantrone, docetaxel regimen increases life expectancy as well as reducing pain and improving quality of life. Oct 6, 2004

First Evidence That Chemotherapy Extends Life in Advanced Prostate Cancer June 2004

Related earlier stories:

• Chemotherapy combination promising for advanced prostate cancer: Taxotere and Emcyt Phase II ReportMay 7, 2001
• Docetaxol (Taxotere) For Advanced Prostate Cancer
• Vitamin D Hormone Mimic May Boost Effectiveness of Radiation Therapy
• Testing High Dose Vitamin D for Prostate Cancer
• Thalidomide in Trials for Prostate and Other Cancers
• Breath test shows if chemo dose is correct for individual - works for Taxotere Uses AntibioticFDA Puts on Fast Track April 24, 2000
• Chemotherapy Using Taxotere "Effective" For Advanced Prostate Cancer

An Anti-Inflammatory Drug (Celebrex) Effectively Treats Men with Recurrent Prostate Cancer. Pfizer announces clinical trial to test the drug for cardiovascular side effects Oct 18 2004

Use of aspirin or other NSAIDs increases survival for men with prostate cancer Oct 4, 2004

Cottonseed drug (Gossypol) boosts cancer treatment in mice Oct 5, 2004

Study identifies which patients can benefit from Iressa, targeted lung cancer drug - and why April 29, 2004

Gene mutations predict which lung cancers will respond to Iressa. April 29, 2004

New Drug For Non-small Cell Lung Cancer Shows Efficacy; Shrinks Tumors In Some Patients And Reduces Symptoms In Others "This compound (Iressa; gefitinib) is the first new way to treat lung cancer in decades, and this is good news," said Dr. Kris, lead investigator of the multi-center trial." Oct 23 2003

Iressa and Other Targeted Therapies Forge Ahead Oct 23, 2003 Following deaths from pneumonia in trials in Japan, Iressa (gefitinib) received fast track approval for non-small cell lung cancer in the USA on the basis of Phase II trials with no undue adverse events and some partial responses.

FACTS ON CANCER

ACS: "Breakthroughs in Cancer Research WHAT'S REAL AND WHAT'S NOT" John R. Seffrin, Ph.D. Chief Executive Officer, American Cancer Society President, International Union Against Cancer Oct 16, 2003

Information on this website is not intended as medical advice nor to be taken as such. Consult qualified physicians specializing in the treatment of prostate cancer. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained on this website.

About Us| Site Archive|Content Policy/Disclaimer| Privacy Policy

---